Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2019

Jun 4, 2019

31971_dirs_2019-06-04_550a91cd-492f-4264-8ec7-54a1756caea5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-05-31

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-31 Common Stock M 650 Acquired 17789 Direct
2019-05-31 Common Stock F 325 $80.48 Disposed 17464 Direct
2019-06-03 Common Stock G 100 Disposed 17364 Direct
2019-06-03 Common Stock G 100 Acquired 200 Indirect
2019-06-03 Common Stock G 100 Disposed 17264 Direct
2019-06-03 Common Stock G 1000 Disposed 16264 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-31 Rsus (restricted Stock Units) $0 M 650 Disposed 2024-06-01 Common Stock (650) Direct

Footnotes

F1: This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.